Aflibercept

403€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Aflibercept
category
Biosimilars
provider
Abbexa
reference
abx831601
tested applications
ELISA, WB
Description
Aflibercept is a recombinant fusion protein biosimilar expressed in CHO cells, targeting VEGFA, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Biosimilars |
Immunogen Target | VEGFA |
Host | Human |
Reactivity | Human |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Monoclonal |
Conjugation | Unconjugated |
Isotype | IgG1 |
Expression | Recombinant |
Purity | > 95% |
Purification | Purified from cell culture supernatants by Protein A/G chromatography. |
Size 1 | 100 µg |
Size 2 | 1 mg |
Form | Liquid |
Tested Applications | ELISA, WB |
Buffer | 0.01 M PBS. pH 7.4. |
Availability | Shipped within 7-12 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Alias | Biosimilars |
Status | RUO |
Note | Concentration: Batch-dependent, typically between 0.5-2.0 mg/ml. CAS Number: 862111-32-8 This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
Androstenedione ELISA
Enzyme immunoassay for the quantitative measurement of androstenedione in serum and EDTA plasma.
Ver Producto
DHEA-S ELISA
Enzyme immunoassay for the direct quantitative determination of DHEA-S in human serum.
Ver Producto